The present invention concerns methods and means for controlling excessiveproliferation and/or migration of smooth muscle cells, and in particular fortreating stenosis, by using antagonists of a native ErbB4 receptor. Theinvention further concerns a method for the identification of ErbB4 agonistsand antagonists capable of inhibiting or enhancing the proliferation ormigration of smooth muscle cells.